Company intelligence / Profile preview

Virax Biolabs

Lanarkshire, Scotland, United Kingdomviraxbiolabs.com ↗
Ownership
Public · VRAX
Employees
~17
Development stage
Commercial
01

Overview

Virax Biolabs has developed a portfolio of diagnostic products focused on measuring T cell responses to viral infections. Their lead platform—ViraxImmune™—enables detailed immunological profiling using advanced ELISpot/FluoroSpot technology. The company’s tests are being clinically validated for use in diagnosing post-infectious syndromes like Long COVID and supporting vaccine efficacy monitoring. No therapeutic drugs are under development.

Therapeutic areas
ImmunologyInfectious Diseases
Modalities
T cell diagnosticsImmunology profiling platformELISpot/FluoroSpot assaysPeptide pools for T cell stimulationAntibodies for detection in ELISA/Flow cytometry/ELISpot
Industry
Protein Biomarker Diagnostics
02

Partnerships

Not specifically listed; the company collaborates with clinics/hospitals/pharma/research institutions as customers or partners.
03

Financials

Market cap
$531.9K
Total revenue
$12.4K
Enterprise value
$-5.6M

Beyond the preview

Go deeper on Virax Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virax Biolabs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call